Orforglipron in type 2 diabetes mellitus and obesity: an overview

This is the authors' abstract. We don't add key points for this paper.

Orforglipron is a promising treatment option for T2DM and overweight or obesity, in terms of glucose control and weight loss. The increased frequency of adverse events, particularly in those receiving high doses and after rapid dose escalation, requires caution before widespread use.